{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T09:34:04Z","timestamp":1792316044808,"version":"4.4.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.urolonc.2007.04.005","type":"journal-article","created":{"date-parts":[[2007,11,30]],"date-time":"2007-11-30T22:55:33Z","timestamp":1196463333000},"page":"137-140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Effect of advanced age on the development of complications from intravesical bacillus Calmette-Gu\u00e9rin therapy"],"prefix":"10.1016","volume":"26","author":[{"given":"Jared G.","family":"Heiner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha K.","family":"Terris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2007.04.005_bib1","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1097\/01.ju.0000073852.24341.4a","article-title":"Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer","volume":"170","author":"Bohle","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2007.04.005_bib2","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1097\/01.ju.0000127757.72243.3e","article-title":"Management of bladder cancer","volume":"171","author":"Lamm","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2007.04.005_bib3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1474-9728.2004.00106.x","article-title":"Immunity and aging: The enemy within?","volume":"3","author":"DeVeale","year":"2004","journal-title":"Aging Cell"},{"key":"10.1016\/j.urolonc.2007.04.005_bib4","series-title":"Campbell\u2019s Urology","first-page":"2789","article-title":"Management of superficial bladder cancer","author":"Malkowicz","year":"2002"},{"issue":"Suppl","key":"10.1016\/j.urolonc.2007.04.005_bib5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000052381","article-title":"BCG intravesical instillations: recommendations for side-effects management","volume":"37","author":"Rischmann","year":"2000","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2007.04.005_bib6","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1345\/aph.19145","article-title":"Management of complications of bacillus Calmette-Guerin immunotherapy in the treatment of bladder cancer","volume":"34","author":"Huang","year":"2000","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.urolonc.2007.04.005_bib7","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/S0022-5347(17)39731-8","article-title":"Fatal sepsis following intravesical bacillus Calmette-Guerin administration for bladder cancer","volume":"144","author":"Rawls","year":"1990","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2007.04.005_bib8","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1016\/S0022-5347(17)37062-3","article-title":"Complications of intravesical bacillus Calmette-Guerin: A case report","volume":"148","author":"Gonzalez","year":"1992","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2007.04.005_bib9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0022-5347(17)43892-4","article-title":"Granulomatous hepatitis following intravesical bacillus Calmette-Guerin therapy for bladder carcinoma","volume":"137","author":"Marans","year":"1987","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2007.04.005_bib10","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1136\/gut.38.4.616","article-title":"Granulomatous hepatitis caused by bacillus Calmette-Guerin (BCG) infection after BCG bladder instillation","volume":"38","author":"Leebeek","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.urolonc.2007.04.005_bib11","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1046\/j.1442-2042.2003.00704.x","article-title":"Acute eosinophilic pneumonia associated with intravesical bacillus Calmette-Guerin therapy of carcinoma in situ of the bladder","volume":"10","author":"Orikasa","year":"2003","journal-title":"Int J Urol"},{"key":"10.1016\/j.urolonc.2007.04.005_bib12","first-page":"253","article-title":"Intravesical bacillus Calmette-Guerin instillation for patients over 80 years old","volume":"44","author":"Kanematsu","year":"1998","journal-title":"Hinyokika Kiyo"},{"key":"10.1016\/j.urolonc.2007.04.005_bib13","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0022-5347(17)43959-0","article-title":"Risks and benefits of repeated courses of intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer","volume":"137","author":"Catalona","year":"1987","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2007.04.005_bib14","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1016\/S0022-5347(05)64994-4","article-title":"Treatment of carcinoma in situ with intravesical bacillus Calmette-Guerin without maintenance","volume":"167","author":"Griffiths","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2007.04.005_bib15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1445-2197.1993.tb00060.x","article-title":"The adverse effect of fibrin-clot inhibiting drugs on intravesical bacillus Calmette-Guerin efficacy for superficial bladder cancer","volume":"63","author":"P\u2019ng","year":"1993","journal-title":"Aust N Z J Surg"},{"key":"10.1016\/j.urolonc.2007.04.005_bib16","first-page":"3726","article-title":"Modulation of fibronectin-mediated Bacillus Calmette-Guerin attachment to murine bladder mucosa by drugs influencing the coagulation pathways","volume":"51","author":"Hudson","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2007.04.005_bib17","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/S0022-5347(17)39741-0","article-title":"Adverse impact of fibrin clot inhibitors on intravesical bacillus Calmette-Guerin therapy for superficial bladder tumors","volume":"144","author":"Hudson","year":"1990","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2007.04.005_bib18","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0022-5347(05)64273-5","article-title":"Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: A meta-analysis of the published results of randomized clinical trials","volume":"168","author":"Sylvester","year":"2002","journal-title":"J Urol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143907001263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143907001263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T09:53:58Z","timestamp":1761040438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143907001263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S1078143907001263"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2007.04.005","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of advanced age on the development of complications from intravesical bacillus Calmette-Gu\u00e9rin therapy","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2007.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}